Belfast-based PathXL’s TissueMark technology launched this week has the potential to transform pathology services worldwide. The technology allows tissue analysis to be carried out remotely, enabling pathologists and pathology skills to be accessed from anywhere in the world.
TissueMark analyses detailed structural patterns in tissue samples and marks the boundaries of potentially cancerous sections for detailed analysis (a process which is otherwise carried out by pathologists hand-marking of slides). A pathologist can mark around one hundred samples per day, while it takes around ten minutes for TissueMark to do so (and in greater detail). TissueMark could therefore accelerate cancer research and discovery, including the advancement of personalized medicine. Thanks to our Editor-In-Chief Donna Cusano for the heads up on this one!
Read more: PathXL Press Release